MyFinsight
Home
Blog
About
Contact
Download
Download image
Sales and maturities
of marketable...
$142,656K
Other assets and
liabilities
-$21,782K
Deposit received for the
sale of b medical...
$9,000K
Depreciation and
amortization
$13,648K
Loss on assets held
for sale
$9,696K
Accounts payable
$4,572K
Stock-based compensation
$4,058K
something is missing
$3,815K
Deferred revenue
$3,195K
Accounts receivable
-$723K
Accrued restructuring
costs
$300K
Net cash provided by
investing activities
$36,772K
Net cash provided by
operating activities
$20,847K
Canceled cashflow
$114,884K
Effects of exchange rate
changes on cash, cash...
$314K
Canceled cashflow
$40,942K
Net increase in
cash, cash...
$55,301K
Canceled cashflow
$2,632K
Purchases of marketable
securities
$108,692K
Purchases of property,
plant and equipment
$6,192K
Net loss
-$15,432K
Inventories
$9,729K
Deferred income taxes
-$5,788K
Accrued compensation
and tax...
-$5,158K
Inventory write-downs and
other asset...
-$4,171K
Amortization and accretion on
marketable securities
$374K
Accrued warranty and
retrofit costs
-$248K
Loss on disposals of
property, plant and...
$42K
Net cash used in
financing activities
-$2,632K
Withholding tax payments on
net share...
$2,418K
Payments of finance
leases
$214K
Back
Back
Cash Flow
source: myfinsight.com
Azenta, Inc. (AZTA)
Azenta, Inc. (AZTA)